Daarsh Innovations

Raipur, India Founded: 2016 • Age: 10 yrs
Antimicrobial products for dermal, intimate, and catheter infections are developed.
Annual revenue $548 Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 11 Brand Intelligence

About Daarsh Innovations

Daarsh Innovations is a company based in Raipur (India) founded in 2016 by Dinesh Aggarwal and Vijay Gupta. Daarsh Innovations operates in a competitive market with competitors including Incyte, Biological E, Vir Biotechnology, LEO Pharma and Vaxcyte, among others.

  • Headquarter Raipur, India
  • Founders Dinesh Aggarwal, Vijay Gupta
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Legal Name Daarsh Innovations Private Limited
  • Date of Incorporation 10 May, 2016
  • Jurisdiction Raipur, Chattisgarh, India
Operational Areas
Healthcare → Healthcare Products & Supplies
Healthcare → Healthcare Products & Supplies
Healthcare → Health Technology & Digital Health
Key Metrics
  • Annual Revenue
    $547.94 (USD)
    0
    as on Mar 31, 2017
  • Net Profit
    -$5.57 K (USD)
    0
    as on Mar 31, 2017
  • EBITDA
    -$5.93 K (USD)
    0
    as on Mar 31, 2017
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Daarsh Innovations

Investments & Acquisitions by Daarsh Innovations

Investments

Financial Statements - Daarsh Innovations

Daarsh Innovations Comparisons

+
Add Comparison
Available on Premium

Competitors of Daarsh Innovations

Daarsh Innovations operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Incyte, Biological E, Vir Biotechnology, LEO Pharma and Vaxcyte, among others.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Small molecules are developed for cancer and skin disease treatments.
domain founded_year HQ Location
Vaccines and therapeutics for multiple diseases are developed and marketed.
domain founded_year HQ Location
Developer of therapeutics for the treatment of infectious diseases
domain founded_year HQ Location
Developer of drugs for treating dermatology diseases
domain founded_year HQ Location
Vaccines for infectious diseases are developed using cell-free protein synthesis.
domain founded_year HQ Location
Novel anti-infectives for bacterial and fungal infections are developed.

Latest news on Daarsh Innovations

Frequently Asked Questions about Daarsh Innovations

Daarsh Innovations was founded in 2016.

Daarsh Innovations is headquartered in Raipur, India. It is registered at Raipur, Chhattisgarh, India.

Dinesh Aggarwal is the current CEO of Daarsh Innovations. They have also founded this company.

Annual revenue of Daarsh Innovations is $547.94 as on Mar 31, 2017.

Developer of antimicrobial products for treating dermal, women intimate area, and catheter infections. The company has developed a Clear topical spray used in the treatments of skin conditions such as Tinea Infections, Tinea Pedis (Athlete Foot), Tinea Cruris (Jock Itch), and others. It provides V Clear drug that helps in treating women intimate area infections caused by bacteria and yeast. The company offers SterCath that is a catheter lock solution that helps patients undergoing hemodialysis, chemotherapy, antibiotic therapy, among others. It reduces the infections within catheters and clot formation at the tip of the catheter.

Daarsh Innovations's top competitors include Vaxcyte, BioNTech and LEO Pharma.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available